Actively hiring
Biotechnology
Oncology Therapeutics
Cell & Gene Therapy
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Venture round
Feb 2026 · 7 mo ago
Grants
$679k
2 grants · CORDIS
The money's age
Fresh money
7 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 27
Raised a round Venture round
Jul 1, 2024
Won a grant $616k · CORDIS
Jun 6, 2024
Raised a round Venture round
Jul 1, 2023
Won a grant $63k · CORDIS
Dec 24, 2020
Founded per the company register
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2026 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Jul 2024 | $616k | — | CORDIS |
| Venture round | Jun 2024 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Jul 2023 | $63k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | STRATOSVIR LIMITED | Companies House |
| Registered | 24 Dec 2020 |
Investors in similar startupsfunds that back the companies most like this one

backs Strike Pharma, Kahrbio

backs Tagworkspharma
Similar startupsby what they do, their industry and backers

Bioarchitech develops multifunctional immunotherapies targeting cancer and virus-related diseases, including innovative viral and RNA-based…

Pioneering the first oral drug for FSHD and advancing cancer treatment solutions.

At Strike Pharma we are shaping a new era of immunotherapy by using our ADAC technology.

KAHR Bio: Pioneering Immunotherapeutics for Advanced Cancer Treatment.

As pioneers of Click-to-Release technology, we are revolutionizing cancer treatment using in vivo click chemistry to increase the…

Accelerate cancer immunotherapy and cancer vaccine development with Alithea Bio's HLA immunopeptidomics platform — neoantigen discovery…



